Safety and Effectiveness of CPI-1189 in HIV-Infected Males on Combination Anti-HIV Drug Therapy

Clinical trial NCT00002209 · COMPLETED

Trial details

NCT number: NCT00002209
Sponsor: Centaur Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

AIDS Dementia Complex HIV Infections

Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.